Skip to main content
SpringerLink
Log in

Cost Effectiveness of Roxithromycin Versus Cefaclor in Australia

  • Correspondence
  • Cost Effectiveness of Roxithromycin Versus Cefaclor in Australia
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Scott WG, Tilyard MW, Dovey SM, et al. Roxithromycin versus cefaclor in lower respiratory tract infection: a generaI practicepharmacoeconomic study. Pharmaco Economics 1993; 4: 122–30

    Article  CAS  Google Scholar 

  2. Bridges-Webb C, Britt H, Miles DA, et al. Morbidity and treatment in generaI practice in Australia 1990–1991. Med J Aust 1992; 157 Suppl. 19 Oct: SI–56

    Google Scholar 

  3. Schedule of Pharmaceutical Benefits for approved pharmacists and medicaI practitioners. August 1993. Canberra: AustralianPublishing Service, 1993

  4. Commonwealth of Australia. Health insurance (1993–1994 generaI medicaI services table) regulations. Schedule of servicesand fees. Canberra: Commonwealth Government Printer,Pharmaco Economics, 1993

Download references

Author information

Authors and Affiliations

  1. Wellington Polytechnic, Wellington, New Zealand

    W. Guy Scott

  2. Delpharm Limited, Auckland, New Zealand

    Bruce C. Cooper

  3. W Guy Scott and Associates Limited, Wellington, New Zealand

    Helen M. Scott

  4. Elaine Gurr Professor of General Practice Otago Medical School, University of Otago, Dunedin, New Zealand

    Murray W. Tilyard

  5. Department of General Practice University of Otago, Dunedin, New Zealand

    Susan M. Dovey

Authors
  1. W. Guy Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce C. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helen M. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murray W. Tilyard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susan M. Dovey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scott, W.G., Cooper, B.C., Scott, H.M. et al. Cost Effectiveness of Roxithromycin Versus Cefaclor in Australia. Pharmacoeconomics 7, 93–94 (1995). https://doi.org/10.2165/00019053-199507010-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507010-00009

Keywords

Search

Navigation